A Phase 1 Study of KHK4083 in Healthy Volunteers and Subjects With Ulcerative Colitis
Status:
Completed
Trial end date:
2017-12-26
Target enrollment:
Participant gender:
Summary
The objectives of this study are to evaluate the safety and tolerability of a single
intravenous (IV) or subcutaneous (SC) dose of KHK4083 in Japanese or White healthy men in a
placebo-controlled, single-blind comparative study, and to evaluate the safety and
tolerability of multiple IV doses of KHK4083 in subjects with ulcerative colitis in an
open-label study.